PTTG1 and growth hormone-producing pituitary gland adenoma: In conclusion, this study proposes that c-miRNAs, especially miR-423-5p, and PTTG1 could be considered valuable biomarkers for the development of new therapeutic strategies against somatotropic adenomas.